1. From the Stanford Stroke Center (M.G.L.), Stanford University Medical Center, Palo Alto, Calif; the Department of Neurology (V.N.T.), University Hospitals of Leuven, Belgium; the Vesalius Research Center (V.N.T.), Leuven, Belgium; and Boehringer Ingelheim Pharma GmbH & Co (E.B.), Germany.